Clinical Trial Update: Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update announcing Johns Hopkins-sponsored Tesamorelin to improve functional outcomes after peripheral nerve injury; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injury

Drugs mentioned

• Tesamorelin (tesamorelin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Peripheral Nerve Injuries | Phase 2 | Status: RECRUITING